RNA5SP410: A Potential Drug Target and Biomarker (G100873662)
RNA5SP410: A Potential Drug Target and Biomarker
RNA5SP410 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell鈥檚 immune response and has been shown to play a critical role in the regulation of inflammation and cancer. In this article, we will explore the biology of RNA5SP410 and its potential as a drug target and biomarker.
Understanding the Biology of RNA5SP410
RNA5SP410 is a non-coding RNA molecule that was identified as a potential drug target and biomarker by researchers at the University of California, San Diego. The molecule is composed of 191 amino acid residues and has a calculated molecular mass of 21.1 kDa. RNA5SP410 is predominantly expressed in the cytoplasm of human cells and is also found in the endoplasmic reticulum (ER) and the nuclear envelope (NE).
RNA5SP410 is a key regulator of the cell鈥檚 immune response. It is part of the T-cell receptor (TCR) complex, which is responsible for cell recognition and activation of the immune response. RNA5SP410 has been shown to play a critical role in the regulation of T-cell development, activation, and function.
RNA5SP410 has also been shown to play a critical role in the regulation of cancer. It has been found to be downregulated in many types of cancer, including breast, lung, and colon cancer. This suggests that RNA5SP410 may be a useful biomarker for cancer diagnosis and treatment.
Potential Drug Target
RNA5SP410 has been shown to be a potential drug target by researchers at the University of California, San Diego. The molecule has been shown to interact with several different proteins, including the protein known as SMAD4. This suggests that RNA5SP410 may be a useful target for small molecules that can modulate the activity of SMAD4.
In addition, RNA5SP410 has also been shown to interact with the protein known as NF-kappa-B. This suggests that RNA5SP410 may be a useful target for drugs that can modulate the activity of NF-kappa-B.
Biomarker Potential
RNA5SP410 has also been shown to have potential as a biomarker for several types of cancer. The molecule has been found to be downregulated in many types of cancer, including breast, lung, and colon cancer. This suggests that RNA5SP410 may be a useful biomarker for cancer diagnosis and treatment.
In addition, RNA5SP410 has also been shown to be downregulated in the endoplasmic reticulum (ER) and the nuclear envelope (NE) in many types of cancer. This suggests that RNA5SP410 may be a useful biomarker for monitoring the effectiveness of cancer treatments.
Conclusion
In conclusion, RNA5SP410 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its biology has been shown to play a critical role in the regulation of the cell鈥檚 immune response and cancer. RNA5SP410 has been shown to interact with several different proteins and may be a useful target for small molecules that can modulate its activity. In addition, RNA5SP410 has also been shown to have potential as a biomarker for several types of cancer. Further research is needed to fully understand the biology of RNA5SP410 and its potential as a drug target and biomarker.
Protein Name: RNA, 5S Ribosomal Pseudogene 410
The "RNA5SP410 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP410 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
RNA5SP425 | RNA5SP437 | RNA5SP44 | RNA5SP444 | RNA5SP450 | RNA5SP456 | RNA5SP463 | RNA5SP464 | RNA5SP465 | RNA5SP479 | RNA5SP493 | RNA5SP496 | RNA5SP497 | RNA5SP505 | RNA5SP511 | RNA5SP518 | RNA5SP52 | RNA5SP53 | RNA5SP54 | RNA5SP57 | RNA5SP63 | RNA5SP85 | RNA5SP91 | RNASE1 | RNASE10 | RNASE11 | RNASE11-AS1 | RNASE12 | RNASE13 | RNASE2 | RNASE2CP | RNASE3 | RNASE4 | RNASE6 | RNASE7 | RNASE8 | RNASE9 | RNASEH1 | RNASEH1-DT | RNASEH2A | RNASEH2B | RNASEH2B-AS1 | RNASEH2C | RNASEH2CP1 | RNASEK | RNASEL | RNASET2 | RND1 | RND2 | RND3 | RNF10 | RNF103 | RNF103-CHMP3 | RNF11 | RNF111 | RNF112 | RNF113A | RNF113B | RNF114 | RNF115 | RNF121 | RNF122 | RNF123 | RNF125 | RNF126 | RNF126P1 | RNF128 | RNF13 | RNF130 | RNF133 | RNF135 | RNF138 | RNF138P1 | RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183
